Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunal Nepali

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Recent Patents on Anti-Cancer Drug Discovery|May 22, 2014
Anticancer hybrids--a patent surveyKunal Nepali, Sahil Sharma, Dinesh Kumar, et al.
Journal of Biomedical Science|September 5, 2022
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenalKunal Nepali, Ram Sharma, Sachin Sharma, et al.
Expert Opinion on Therapeutic Patents|November 15, 2016
An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015)Ritu Ojha, Jagjeet Singh, Anu Ojha, et al.
Cancer Letters|March 4, 2025
Advancing glioblastoma therapy: Learning from the past and innovations for the futureMandeep Rana, Ke-Chi Liou, Amandeep Thakur, et al.
Archiv Der Pharmazie|October 19, 2012
Design and synthesis of aza-flavones as a new class of xanthine oxidase inhibitorsRajni Dhiman, Sahil Sharma, Gagandip Singh, et al.
Expert Opinion on Investigational Drugs|August 3, 2024
Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agentsCharanjit Kaur, Amandeep Thakur, Ke-Chi Liou, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 1, 2014
Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitorsHarpreet S Virdi, Sahil Sharma, Samir Mehndiratta, et al.
Recent Patents on Anti-Cancer Drug Discovery|June 11, 2013
Tubulin inhibitors: a patent surveyKunal Nepali, Ritu Ojha, Sahil Sharma, et al.
European Journal of Medicinal Chemistry|April 2, 2014
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybridsKunal Nepali, Sahil Sharma, Manmohan Sharma, et al.
European Journal of Medicinal Chemistry|May 10, 2024
Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditionsAmandeep Thakur, Mandeep Rana, Anshul Mishra, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Recent Patents on Anti-Cancer Drug Discovery|May 22, 2014
Anticancer hybrids--a patent surveyKunal Nepali, Sahil Sharma, Dinesh Kumar, et al.
Journal of Biomedical Science|September 5, 2022
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenalKunal Nepali, Ram Sharma, Sachin Sharma, et al.
Expert Opinion on Therapeutic Patents|November 15, 2016
An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015)Ritu Ojha, Jagjeet Singh, Anu Ojha, et al.
Cancer Letters|March 4, 2025
Advancing glioblastoma therapy: Learning from the past and innovations for the futureMandeep Rana, Ke-Chi Liou, Amandeep Thakur, et al.
Archiv Der Pharmazie|October 19, 2012
Design and synthesis of aza-flavones as a new class of xanthine oxidase inhibitorsRajni Dhiman, Sahil Sharma, Gagandip Singh, et al.
Expert Opinion on Investigational Drugs|August 3, 2024
Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agentsCharanjit Kaur, Amandeep Thakur, Ke-Chi Liou, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 1, 2014
Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitorsHarpreet S Virdi, Sahil Sharma, Samir Mehndiratta, et al.
Recent Patents on Anti-Cancer Drug Discovery|June 11, 2013
Tubulin inhibitors: a patent surveyKunal Nepali, Ritu Ojha, Sahil Sharma, et al.
European Journal of Medicinal Chemistry|April 2, 2014
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybridsKunal Nepali, Sahil Sharma, Manmohan Sharma, et al.
European Journal of Medicinal Chemistry|May 10, 2024
Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditionsAmandeep Thakur, Mandeep Rana, Anshul Mishra, et al.
Pageof 9